Ovulation induction in women with polycystic ovary syndrome: Randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy

Reproductive BioMedicine Online

Volumn 9, Issue 4, 2004, Pages 382-390

  López, Eugenio ^a   Gunby, Joanne ^b   Daya, Salim ^b   Parrilla, Juan J ^a   Abad, Lorenzo ^a   Balasch, Juan ^c,d  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Clomiphene citrate; FSH; Ovulation induction; PCOS

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; PROFASIS; RECOMBINANT FOLLITROPIN;

ADULT; AGE; ANDROSTENEDIONE BLOOD LEVEL; ANOVULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FEMALE INFERTILITY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MONITORING; MULTICENTER STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREDICTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

EID: 5044229972     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61273-4     Document Type: Article

References (33)

1. Adams J, Polson DW, Franks S 1986 Prevalence of polycystic ovaries in women with anovulation or idiopathic hirsutism. Brithis Medical Journal 293, 355-359.
2. American College of Obstetricians and Gynecologists 2002 ACOG Practice Bulletin. Management of infertility caused by ovulatory dysfunction. Obstetrics and Gynecology 99, 347-358.
3. Balasch J 1986 Empleo del citrato de clomifeno y del epimestrol para la inducción de la ovulación. Clinica Ginecológica 10, 40-59.
4. Balasch J, Ballescá JL, Pimentel C et al. 1994 Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles. Human Reproduction 9, 1863-1866.
5. Balasch J, Tur R, Peinado JA 1996 The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. Journal of Assisted Reproduction and Genetics 13, 551-556.
6. Balasch J, Fábregues F, Peñarrubia J et al. 1998 Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO Group II anovulatory infertile patients. Journal of Assisted Reproduction and Genetics 15, 552-559.
7. Balen A 1997 Anovulatory infertility and ovulation induction. Journal of the British Fertility Society 2, 83-87.
8. Cheang KI, Nestler JE 2004 Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? Reproductive BioMedicine Online 8, 440-447.
9. Coelingh-Bennink HJT, Fauser BCJM, Out HJ 1998 Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. Fertility and Sterility 69, 19-25.
10. Crosignani PG, Colombo M, Vegetti W et al. 2003 Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Human Reproduction 18, 1928-1932.
11. Dickey RP, Holtkamp DE 1996 Development, pharmacology and clinical experience with clomiphene citrate. Human Reproduction Update 2, 483-506.
12. Edwards RG, Lobo RA, Bouchard P 1997 Why delay the obvious need for milder forms of ovarian stimulation? Human Reproduction 12, 399-401.
13. Erickson GF, Hsueh AJW, Quigley ME et al. 1979 Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 49, 514-519.
14. Fauser BCJM, van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews 18, 71-106.
15. Gelety TJ, Kerin JF, Surrey ES 1992 Ovarian hyperstimulation syndrome. Infertility and Reproductive Medicine Clinics of North America 3, 795-809.
16. Golan A, Ron-El R, Herman A et al. 1989 Ovarian hyperstimulation syndrome: an update review. Obstetrics and Gynecological Survey 44, 430-440.
17. Homburg R 1998 Adverse effects of luteinizing hormone on fertility: fact or fantasy. Baillière's Clinical Obstetrics and Gynaecology 12, 555-563.
18. Homburg R, Howles CM 1999 Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Human Reproduction Update 5, 493-499.
19. Homburg R, Insler V 2002 Ovulation induction in perspective. Human Reproduction Update 8, 449-462.
20. Kousta E, White DM, Franks S 1997 Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update 3, 359-365.
21. Lord JM, Flight IH, Norman RJ 2003 Metformin in polycystic ovary syndrome: systematic review and meta-analysis. British Medical Journal 327, 951-953.
22. Manau D, Arroyo V, Jiménez W et al. 2002 Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines. Fertility and Sterility 77, 1178-1183.
23. Matorras R, Diaz T, Corcostegui B et al. 2002 Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. Human Reproduction 17, 2107-2111.
24. Norman RJ, Noakes M, Wu R et al. 2004 Improving reproductive performance in overweight/obese women with effective weight management. Human Reproduction Update 10, 267-280.
25. Out HJ, Coelingh-Bennink HJT 1998 Clomiphene citrate or gonadotrophins for ovulation induction? Human Reproduction 13, 2358-2361.
26. Pasquali R, Gambineri A 2004 Role of changes in dietary habits in polycystic ovary syndrome. Reproductive BioMedicine Online 8, 431-439.
27. Rizk B, Aboulghar M, Smitz J, Ron-El R 1997 The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Human Reproduction Update 3, 255-266.
28. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19, 41-47.
29. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AMA 2000 WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. Cambridge University Press, Cambridge, UK.
30. Seibel MM, Kamreva MM, MacArdle C, Taymor ML 1984 Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation. International Journal of Fertility 29, 39-43.
31. Taymor ML 1996 The regulation of follicle growth: some clinical implications in reproductive endocrinology. Fertility and Sterility 65, 235-247.
32. van Wely M, Bayram N, van der Veen F 2003 Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review. Human Reproduction 28, 2243-2249.
33. Yarali H, Zeyneloglu HB 2004 Gonadotrophin treatment in patients with polycystic ovary syndrome. Reproductive BioMedicine Online 8, 528-537.